
Spineway
ALSPW | PA
Overview
Corporate Details
- ISIN(s):
- FR0011398874 (+2 more)
- LEI:
- 969500CMAIZOJBR35333
- Country:
- France
- Address:
- 7 ALLEE DU MOULIN BERGER, 69130 ECULLY
- Website:
- https://spineway.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Spineway is a medical technology company specializing in the design, development, and manufacture of innovative implants and surgical instruments for the treatment of severe spinal disorders. Its product portfolio includes posterior osteosynthesis systems, such as the VEOS-KAPHORN modular platform, and motion-preservation solutions like the LP-ESP and CP-ESP viscoelastic disc prostheses for lumbar and cervical applications. The company serves spine surgeons globally, distributing its products in over 50 countries. A key differentiator is its commitment to surgeon partnership through comprehensive training programs, including hands-on courses and OR training, to support practitioners in using its advanced surgical techniques. Founded in 2005, Spineway has expanded its offerings through strategic acquisitions, including Distimp (2021) and Spine Innovations (2022), to broaden its product range and market reach.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Spineway.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-03 18:34 |
Regulatory News Service
SPINEWAY : Approbation du GMED pour la nouvelle ligne de production dédiée aux …
|
French | 230.5 KB | |
2025-06-06 18:32 |
Post-Annual General Meeting Information
Spineway : Minutes of the General Meeting of June 4, 2025
|
English | 258.9 KB | |
2025-06-06 18:32 |
Post-Annual General Meeting Information
SPINEWAY : Compte-rendu de l’Assemblée Générale du 4 juin 2025
|
French | 314.4 KB | |
2025-05-19 18:30 |
Pre-Annual General Meeting Information
SPINEWAY : Assemblée Générale Mixte du 4 juin 2025 - Mise à disposition des doc…
|
French | 312.8 KB | |
2025-05-19 18:30 |
Pre-Annual General Meeting Information
Spineway : Combined General Meeting of June 4, 2025 - Availability of preparato…
|
English | 296.5 KB | |
2025-04-16 19:10 |
Quarterly Report
Spineway : First-quarter 2025 revenue of €2.8 million
|
English | 298.2 KB | |
2025-04-16 19:00 |
Earnings Release
SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€
|
French | 325.1 KB | |
2025-03-24 18:00 |
Earnings Release
SPINEWAY : Résultats annuels 2024 consolidés - Résultat d’exploitation proche d…
|
French | 347.5 KB | |
2025-03-24 18:00 |
Earnings Release
Spineway : Consolidated 2024 annual results - Operating income close to breakev…
|
English | 299.8 KB | |
2025-03-21 08:45 |
Legal Proceedings Report
SPINEWAY : Point sur la procédure judiciaire contre Strategos
|
French | 254.1 KB | |
2025-02-27 18:30 |
Regulatory News Service
Spineway marks its return to Arab Health 2025 with new distribution agreements
|
English | 285.4 KB | |
2025-02-27 18:30 |
Regulatory News Service
SPINEWAY marque son retour au salon Arab Health 2025 avec de nouveaux contrats …
|
French | 308.5 KB | |
2025-01-22 18:30 |
Earnings Release
Spineway : Chiffre d’affaires annuel 2024 de 12 M€ - Croissance de 14% par rapp…
|
French | 215.5 KB | |
2025-01-22 18:30 |
Earnings Release
Spineway : 2024 revenue of €12 million - 14% growth compared with 2023
|
English | 212.2 KB | |
2024-12-18 18:00 |
Regulatory News Service
SPINEWAY obtient de nouvelles homologations au Vietnam et enregistre des premiè…
|
French | 349.6 KB |
Automate Your Workflow. Get a real-time feed of all Spineway filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Spineway via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |